GlaxoSmithKline Pharmaceuticals Ltd (GLAXO):企業財務及び戦略的SWOT分析

GlobalDataが発行した調査報告書(GDPH113643FSA)
◆英語タイトル:GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH113643FSA
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年2月15日
◆ページ数:41
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GlaxoSmithKline Pharmaceuticals Ltd (GSK India) is a pharmaceutical company that manufactures and markets prescription medicines and vaccines. The prescription medicines range across therapeutic areas such as, analgesic, anti-infective, anti-inflammatory, anti parasitic, cardiovascular, dermatology, diabetes, endocrine, gastrointestinal, gynaecology, immunosupressants, nutritional, respiratory, central nervous system (CNS) and oncology. The company offers a range of vaccines for the prevention of hepatitis A, hepatitis B, influenzae, diphtheria, tetanus, pertussis, rotavirus, tetanus toxoid, reduced diphtheria toxoid, human papillomavirus vaccine and others. The company is a subsidiary of GlaxoSmithKline Plc, which has operations across pharmaceuticals, vaccines and consumer health domains. GSK India is headquartered in Mumbai, Maharashtra, India.

GlaxoSmithKline Pharmaceuticals Ltd Key Recent Developments

Oct 27, 2016: GlaxoSmithKline Pharmaceuticals announces a 12% Sales growth for the Quarter Ended 30 September, 2016
Jul 28, 2016: GlaxoSmithKline Pharmaceuticals delivers Q1 performance of 8% Sales growth
Mar 04, 2016: WNS Extends Contract with GSK to Provide High-end Analytical Services
Feb 08, 2016: Biogen Joins Pioneering Target Validation Collaboration
Jan 12, 2016: Kuehne + Nagel and GlaxoSmithKline sign long term global logistics partnership contract

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Section 1 – About the Company 5
GlaxoSmithKline Pharmaceuticals Ltd – Key Facts 5
GlaxoSmithKline Pharmaceuticals Ltd – Key Employees 6
GlaxoSmithKline Pharmaceuticals Ltd – Key Employee Biographies 7
GlaxoSmithKline Pharmaceuticals Ltd – Major Products and Services 8
GlaxoSmithKline Pharmaceuticals Ltd – History 13
GlaxoSmithKline Pharmaceuticals Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Section 2 – Company Analysis 16
GlaxoSmithKline Pharmaceuticals Ltd – Business Description 16
GlaxoSmithKline Pharmaceuticals Ltd – Corporate Strategy 17
GlaxoSmithKline Pharmaceuticals Ltd – SWOT Analysis 18
SWOT Analysis – Overview 18
GlaxoSmithKline Pharmaceuticals Ltd – Strengths 18
GlaxoSmithKline Pharmaceuticals Ltd – Weaknesses 19
GlaxoSmithKline Pharmaceuticals Ltd – Opportunities 20
GlaxoSmithKline Pharmaceuticals Ltd – Threats 21
GlaxoSmithKline Pharmaceuticals Ltd – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 26
Financial Performance 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29
GlaxoSmithKline Pharmaceuticals Ltd, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
Oct 27, 2016: GlaxoSmithKline Pharmaceuticals announces a 12% Sales growth for the Quarter Ended 30 September, 2016 31
Jul 28, 2016: GlaxoSmithKline Pharmaceuticals delivers Q1 performance of 8% Sales growth 32
Mar 04, 2016: WNS Extends Contract with GSK to Provide High-end Analytical Services 33
Feb 08, 2016: Biogen Joins Pioneering Target Validation Collaboration 34
Feb 08, 2016: Biogen Joins Pioneering Target Validation Collaboration 35
Jan 12, 2016: Kuehne + Nagel and GlaxoSmithKline sign long term global logistics partnership contract 36
Section 6 – Appendix 37
Methodology 37
Ratio Definitions 37
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
GlaxoSmithKline Pharmaceuticals Ltd, Key Facts 5
GlaxoSmithKline Pharmaceuticals Ltd, Key Employees 6
GlaxoSmithKline Pharmaceuticals Ltd, Key Employee Biographies 7
GlaxoSmithKline Pharmaceuticals Ltd, Major Products and Services 8
GlaxoSmithKline Pharmaceuticals Ltd, History 13
GlaxoSmithKline Pharmaceuticals Ltd, Joint Venture 15
GlaxoSmithKline Pharmaceuticals Ltd, Key Competitors 22
GlaxoSmithKline Pharmaceuticals Ltd, Ratios based on current share price 23
GlaxoSmithKline Pharmaceuticals Ltd, Annual Ratios 24
GlaxoSmithKline Pharmaceuticals Ltd (Cont...1), Annual Ratios 25
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29
GlaxoSmithKline Pharmaceuticals Ltd, Recent Deals Summary 30
Currency Codes 37
Capital Market Ratios 37
Equity Ratios 38
Profitability Ratios 38
Cost Ratios 39
Liquidity Ratios 39
Leverage Ratios 39
Efficiency Ratios 40

List of Figures
GlaxoSmithKline Pharmaceuticals Ltd, Performance Chart (2012 - 2016) 26
GlaxoSmithKline Pharmaceuticals Ltd, Ratio Charts 27
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 29

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ GlaxoSmithKline Pharmaceuticals Ltd (GLAXO):企業財務及び戦略的SWOT分析(GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆